Pharmaceutical Investing Auris Medical Closes Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD
Pharmaceutical Investing Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
